Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up (Q44528029)
Jump to navigation
Jump to search
scientific article published on 10 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up |
scientific article published on 10 July 2013 |
Statements
1 reference
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up (English)
1 reference
Arzu Didem Yalcin
1 reference
Seçil Uçar
1 reference
Saadet Gumuslu
1 reference
Ludwig G Strauss
1 reference
10 July 2013
1 reference
1 reference
35
1 reference
4
1 reference
524-527
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference